PL337004A1 - Vascular adhesion protein exhibiting activity similar to that of amine oxidase - Google Patents

Vascular adhesion protein exhibiting activity similar to that of amine oxidase

Info

Publication number
PL337004A1
PL337004A1 PL98337004A PL33700498A PL337004A1 PL 337004 A1 PL337004 A1 PL 337004A1 PL 98337004 A PL98337004 A PL 98337004A PL 33700498 A PL33700498 A PL 33700498A PL 337004 A1 PL337004 A1 PL 337004A1
Authority
PL
Poland
Prior art keywords
activity similar
adhesion protein
amine oxidase
exhibiting activity
protein exhibiting
Prior art date
Application number
PL98337004A
Other versions
PL192459B1 (en
Inventor
Sirpa Jalkanen
Marko Salmi
David John Smith
Petri Bono
Original Assignee
Biotie Therapies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25338478&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL337004(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biotie Therapies Ltd filed Critical Biotie Therapies Ltd
Publication of PL337004A1 publication Critical patent/PL337004A1/en
Publication of PL192459B1 publication Critical patent/PL192459B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0014—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)
    • C12N9/0022—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL337004A 1997-05-23 1998-05-22 Vascular adhesion protein exhibiting activity similar to that of amine oxidase PL192459B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86243397A 1997-05-23 1997-05-23
PCT/FI1998/000429 WO1998053049A1 (en) 1997-05-23 1998-05-22 Vascular adhesion protein-1 having amine oxidase activity

Publications (2)

Publication Number Publication Date
PL337004A1 true PL337004A1 (en) 2000-07-31
PL192459B1 PL192459B1 (en) 2006-10-31

Family

ID=25338478

Family Applications (1)

Application Number Title Priority Date Filing Date
PL337004A PL192459B1 (en) 1997-05-23 1998-05-22 Vascular adhesion protein exhibiting activity similar to that of amine oxidase

Country Status (12)

Country Link
EP (1) EP0979271A1 (en)
JP (1) JP2001507238A (en)
KR (1) KR100533911B1 (en)
CN (1) CN1269829A (en)
AU (1) AU742098B2 (en)
CA (1) CA2289903A1 (en)
HU (1) HUP0002234A3 (en)
NO (1) NO995725D0 (en)
NZ (1) NZ501118A (en)
PL (1) PL192459B1 (en)
RU (1) RU2204838C2 (en)
WO (1) WO1998053049A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7285416B2 (en) 2000-01-24 2007-10-23 Gendaq Limited Regulated gene expression in plants
EP1362120A1 (en) * 2001-02-23 2003-11-19 Biovitrum Ab Method for purification of soluble ssao
FI20020807A0 (en) * 2002-04-29 2002-04-29 Biotie Therapies Oyj Novel humanized anti-VAP-1 monoclonal antibodies
CA2526675A1 (en) 2003-05-26 2004-12-02 Biotie Therapies Corporation Crystalline vap-1 and uses thereof
FI20050640A0 (en) * 2005-06-16 2005-06-16 Faron Pharmaceuticals Oy Compounds for treating or preventing diseases or disorders related to amine oxidases
RU2009130380A (en) 2007-01-10 2011-02-20 Санофи-Авентис (Fr) METHOD FOR DETERMINING ORGANIC METHYLENENINE STABILITY IN THE PRESENCE OF SEMICARBASIDE-SENSITIVE AMINOXIDASE
FI20075278A0 (en) * 2007-04-20 2007-04-20 Biotie Therapies Corp Novel completely human anti-VAP-1 monoclonal antibodies
UA112154C2 (en) * 2009-09-08 2016-08-10 Біоті Терапіс Корп. Use of vap-1 inhibitors for treating fibrotic conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US39447A (en) * 1863-08-04 Improvement in truss-bridges
NZ253151A (en) * 1992-06-09 1997-03-24 Sirpa Jalkanen Human endothelial vascular adhesion protein-1 (vap-1), antibodies, methods of diagnosis and pharmaceutical compositions

Also Published As

Publication number Publication date
HUP0002234A2 (en) 2000-10-28
JP2001507238A (en) 2001-06-05
AU742098B2 (en) 2001-12-20
KR20010012920A (en) 2001-02-26
WO1998053049A1 (en) 1998-11-26
NO995725L (en) 1999-11-22
NZ501118A (en) 2002-08-28
HUP0002234A3 (en) 2005-11-28
KR100533911B1 (en) 2005-12-06
AU7531498A (en) 1998-12-11
CA2289903A1 (en) 1998-11-26
CN1269829A (en) 2000-10-11
PL192459B1 (en) 2006-10-31
NO995725D0 (en) 1999-11-22
EP0979271A1 (en) 2000-02-16
RU2204838C2 (en) 2003-05-20

Similar Documents

Publication Publication Date Title
PL336889A1 (en) Preparations of activated protein c
EP0985017A4 (en) Cleaning compositions having enhanced enzyme activity
FI971749A (en) Enzyme with lipolytic activity
DE69827245D1 (en) EARRINGS TO REDUCE NOISE
LT98001A (en) Small molecule inhibitors of rotamase enzyme activity
AU2805897A (en) Inhibitors of protein farnesyltransferase
IL130300A0 (en) Inhibitors of the enzymatic activity of PSA
HUP9900323A2 (en) Recombinant protein having bacteriophage endosialidase enzymatic activity
GB9616282D0 (en) Enzyme activity enhancement
HUP9702242A3 (en) Inozitol-glykanes of inzulin-like activity
PL334975A1 (en) Application of gasto-intestinal lipase inhibitors
EP0994707A4 (en) Inhibitors of naaladase enzyme activity
PL342500A1 (en) Derivatives of pyrolydin-3-carboxylic acid and their application as endothelin antagonists
PL337004A1 (en) Vascular adhesion protein exhibiting activity similar to that of amine oxidase
ZA983065B (en) Inhibitors of protein farnesyltranferase
HUP0004931A3 (en) Synthesis of betha-lactam antibacterials using soluble side chain esters and enzyme acylase, intermediates
GB9216582D0 (en) Determination of enzyme activity
PL328221A1 (en) Novel derivatives of urea
FR2747308B1 (en) ASSOCIATION OF MARGOUSIER, (-) HYDROXYCITRATE AND CERAMIDES AND COMPOSITIONS CONTAINING THEM
ATA102994A (en) FLUORESCENCE DETERMINATION OF LIPOLYTIC ENZYME ACTIVITY
ATE218809T1 (en) COMBINATION OF ENZYMES
DE69533002D1 (en) Process for the preparation of intermediates of inhibitors of enzyme converting enkephalinase and angiotensin and intermediates thereof
GB9713139D0 (en) Use of enzymes
AU1478100A (en) Kell protein proteolytic activity
AU8999298A (en) Protein having activity of activiting nerve cell functions

Legal Events

Date Code Title Description
RECP Rectifications of patent specification